Cargando…

Systematic review and meta-analysis of prognostic factors for idiopathic inflammatory myopathy-associated interstitial lung disease

OBJECTIVE: To clarify prognostic factors for idiopathic inflammatory myopathy (IIM)-associated interstitial lung disease (ILD). DESIGN: Systematic review and meta-analysis using the Grades of Recommendation, Assessment, Development and Evaluation system. DATA SOURCES: Medline, EMBASE and Science Cit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kamiya, Hiroyuki, Panlaqui, Ogee Mer, Izumi, Shinyu, Sozu, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Respiratory Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303632/ https://www.ncbi.nlm.nih.gov/pubmed/30559160 http://dx.doi.org/10.1136/bmjopen-2018-023998

Ejemplares similares

Prognostic factors of idiopathic inflammatory myopathies complicated with interstitial lung disease: protocol for a systematic review and meta-analysis
por: Kamiya, Hiroyuki, et al.
Publicado: (2016)

Systematic review and meta-analysis of the prognosis and prognostic factors of interstitial pneumonia with autoimmune features
por: Kamiya, Hiroyuki, et al.
Publicado: (2019)

Systematic review and meta-analysis of prognostic factors of acute exacerbation of idiopathic pulmonary fibrosis
por: Kamiya, Hiroyuki, et al.
Publicado: (2020)

Prognostic factors for acute exacerbation of idiopathic pulmonary fibrosis: protocol for a systematic review and meta-analysis
por: Kamiya, Hiroyuki, et al.
Publicado: (2019)

Systematic review and meta-analysis of the risk of rheumatoid arthritis-associated interstitial lung disease related to anti-cyclic citrullinated peptide (CCP) antibody
por: Kamiya, Hiroyuki, et al.
Publicado: (2021)

Prognostic significance of autoantibodies for idiopathic pulmonary fibrosis: protocol for a systematic review
por: Kamiya, Hiroyuki, et al.
Publicado: (2018)

Systematic review and meta-analysis of clinical significance of autoantibodies for idiopathic pulmonary fibrosis
por: Kamiya, Hiroyuki, et al.
Publicado: (2019)

A systematic review of the incidence, risk factors and prognosis of acute exacerbation of systemic autoimmune disease-associated interstitial lung disease
por: Kamiya, Hiroyuki, et al.
Publicado: (2021)

The efficacy of recombinant human soluble thrombomodulin (rhsTM) treatment for acute exacerbation of idiopathic pulmonary fibrosis: a systematic review and meta-analysis
por: Kamiya, Hiroyuki, et al.
Publicado: (2020)

A systematic review of the efficacy of direct hemoperfusion with a polymyxin B–immobilized fibre column to treat rapidly progressive interstitial pneumonia
por: Kamiya, Hiroyuki, et al.
Publicado: (2019)

Idiopathic inflammatory myopathies and the lung
por: Lega, Jean-Christophe, et al.
Publicado: (2015)

Efficacy and Tolerability of Nintedanib in Idiopathic-Inflammatory-Myopathy-Related Interstitial Lung Disease: A Pilot Study
por: Liang, Junyu, et al.
Publicado: (2021)

Potential risk of TNF inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis
por: Nakashita, Tamao, et al.
Publicado: (2014)

Effects of Nintedanib on Quantitative Lung Fibrosis Score in Idiopathic Pulmonary Fibrosis
por: Lancaster, Lisa, et al.
Publicado: (2020)

Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control study
por: Hozumi, Hironao, et al.
Publicado: (2013)

Interstitial Lung Disease Associated Acute Respiratory Failure Requiring Invasive Mechanical Ventilation: A Retrospective Analysis
por: Vahdatpour, Cyrus A., et al.
Publicado: (2020)

Predictors and Mortality of Rapidly Progressive Interstitial Lung Disease in Patients With Idiopathic Inflammatory Myopathy: A Series of 474 Patients
por: Li, Yuhui, et al.
Publicado: (2020)

Acute Exacerbation of Interstitial Lung Disease in Adult Patients With Idiopathic Inflammatory Myopathies: A Retrospective Case-Control Study
por: Liang, Junyu, et al.
Publicado: (2020)

Biomarkers and Autoantibodies of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies
por: Yoshifuji, Hajime
Publicado: (2016)

Recent Treatment of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies
por: Kawasumi, Hidenaga, et al.
Publicado: (2015)

Predictors of progression in idiopathic inflammatory myopathies with interstitial lung disease
por: Cao, Heng, et al.
Publicado: (2022)

Systematic review and network meta-analysis of approved medicines for the treatment of idiopathic pulmonary fibrosis
por: Skandamis, Aristeidis, et al.
Publicado: (2019)

Inflammatory Myopathy-Related Interstitial Lung Disease: From Pathophysiology to Treatment
por: Hervier, Baptiste, et al.
Publicado: (2020)

Features and predictive value of 6-min walk test outcomes in interstitial lung disease: an observation study using wearable monitors
por: Li, Jiaying, et al.
Publicado: (2022)

Efficacy of N-acetylcysteine on idiopathic or postinfective non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis protocol
por: Luo, Ai, et al.
Publicado: (2022)

Efficacy and safety of pirfenidone in the treatment of idiopathic pulmonary fibrosis patients: a systematic review and meta-analysis of randomised controlled trials
por: Wu, Wenjuan, et al.
Publicado: (2021)

Study protocol for a randomised, placebo-controlled, single-blind phase II study of the efficacy of morphine for dyspnoea in patients with interstitial lung disease (JORTC-PAL 15)
por: Matsuda, Yoshinobu, et al.
Publicado: (2021)

Comparison of high-intensity interval training versus moderate-intensity continuous training in pulmonary rehabilitation for interstitial lung disease: a randomised controlled pilot feasibility trial
por: Nikoletou, Dimitra, et al.
Publicado: (2023)

A cohort study of mortality predictors in patients with acute exacerbation of chronic fibrosing interstitial pneumonia
por: Usui, Yutaka, et al.
Publicado: (2013)

Survival of Patients With Idiopathic Inflammatory Myopathies in Slovenia
por: Hočevar, Alojzija, et al.
Publicado: (2021)

Role of antifibrotics in the management of idiopathic inflammatory myopathy associated interstitial lung disease
por: Wilfong, Erin M., et al.
Publicado: (2021)

Protocol for a systematic review of the associations between inflammatory markers and lung function, muscle force and exercise capacity in people with COPD
por: Noor, Nadhirah Mohd, et al.
Publicado: (2023)

Exploration of the unmet needs of patients diagnosed with idiopathic pulmonary fibrosis: a scoping review protocol
por: Bramhill, Carita, et al.
Publicado: (2023)

Microbial communities in the respiratory tract of patients with interstitial lung disease
por: Garzoni, Christian, et al.
Publicado: (2013)

Idiopathic Pulmonary Fibrosis Registry China study (PORTRAY): protocol for a prospective, multicentre registry study
por: Xie, Bingbing, et al.
Publicado: (2020)

Prognosis of acute exacerbation in idiopathic pulmonary fibrosis with pulmonary emphysema: a retrospective cohort study in Japan
por: Horio, Yukihiro, et al.
Publicado: (2022)

Efficacy and safety of whole-lung lavage for pulmonary alveolar proteinosis: a protocol for a systematic review and meta-analysis
por: Liu, Shixu, et al.
Publicado: (2022)

Retrospective observational study of trends in hospital admissions for idiopathic pulmonary fibrosis in Spain (2004–2013) using administrative data
por: Pedraza-Serrano, Fernando, et al.
Publicado: (2017)

Efficacy and safety of nintedanib in Japanese patients with early-stage idiopathic pulmonary fibrosis: a study protocol for an observational study
por: Sakamoto, Noriho, et al.
Publicado: (2021)

Clinical spectrum and outcomes of idiopathic inflammatory myopathies in South Africans
por: Birch, Candice, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_98udgl37b96344f0r1f44h2rjc